Women on “skinny jabs” must use effective contraception, MHRA urges in latest guidance

Contributed by: UK Government and Public Sector

Tags

Government

Weight

More Like This

MHRA approves GLP –1 receptor agonist semaglutide to reduce risk of serious heart problems in obese or overweight adults

Two in Three Patients Hide Weight Loss Treatment, UK Study Finds

2 in 3 patients hide weight loss treatment from friends and family, new UK study finds

EADV Congress 2025: GLP-1RA drugs dramatically reduce death and cardiovascular risk in psoriasis patients

GlobeNewswire associated0

Lyv Launches in the UK to Support The 500,000 Patients Going Private for Weight Loss Treatment

GLP-1 weight loss drugs set to reshape UK dairy demand

WEIGHT LOSS MEDICATIONS LINKED TO REDUCTION IN BOTH FOOD AND ALCOHOL CONSUMPTION, LATEST RESEARCH REVEALS

PR Newswire associated0

Wegovy® pill demonstrated greater weight loss than orforglipron and lower odds of stopping medication due to side effects in a new indirect comparison to be presented at Obesity Medicine Association 2026